Measured Impact. Proven Results.
At Precision Motion Health (PMH), outcomes are more than metrics—they are measurable transformations in human motion, workforce health, and financial performance. Our FDA-cleared Electromyographic Functional Assessment (EFA) technology combines data, science, and AI analytics to convert raw data into actionable recovery intelligence.
PMH stands at the intersection of innovation and evidence—an advancement echoing the research highlighted in “Emerging Diagnostic Approaches for Musculoskeletal Disorders”, where the future of musculoskeletal assessment is defined by objective data, digital biomarkers, and clinical analytics. PMH brings that future to life.
Quantified Outcomes Across Industries
Backed by more than a decade of data and deployments across Fortune 500 clients, PMH delivers objective, defensible, and scalable outcomes that redefine how organizations measure success in musculoskeletal health.
- 92% of post-incident cases result in no claim paid.
- $150 million+ in cumulative claim cost reduction across Fortune 500 clients since 2016.
- 200,000+ employees supported through baseline and post-incident assessments.
- 683% ROI demonstrated in one national transportation case study.
- 30–60% reduction in musculoskeletal claims costs reported within 12 months of adoption.
Example Fortune 500 Case Insights
PMH’s EFA-STM Program has proven transformative across multiple sectors—transportation, logistics, food production, and healthcare—delivering verifiable improvements in safety, cost, and care outcomes.
Case A — National Logistics Company
Implemented PMH’s baseline and post-incident testing across 45 terminals nationwide. Within 18 months, Total Recordable Incident Rate (TRIR) decreased by 41%, and average claim duration fell from 38 days to 11 days. Estimated savings exceeded $8.7 million in the first year.
Case B — Fortune 500 Food Distribution Partner
Adopted remote EFA kits and tele-review model for dispersed sites. The hybrid deployment reduced claim resolution time from 72 days to 15 days and delivered 3× ROI through decreased litigation exposure and improved return-to-work velocity.
Scientific Validation Meets Real-World Application
PMH operationalizes the diagnostic advancements outlined in peer-reviewed literature—bridging the gap between academic discovery and occupational practice. Our EFA-based analytics platform quantifies electromyographic, range-of-motion, and force vector data into a unified model that guides treatment precision.
These capabilities reflect the very direction of modern musculoskeletal science—objective diagnostics, non-invasive data capture, and AI-assisted interpretation—making PMH a living embodiment of the next generation of musculoskeletal intelligence.
Validated by:
- FDA registration (Class II medical device)
- Acceptance under Daubert Standard for Federal admissibility
- Compliance with ADA, EEOC, CMS and OSHA guidelines
- Benchmark alignment with emerging academic frameworks
Beyond Data — Human Impact
Behind every metric is a worker who avoided unnecessary surgery, an employer who sustained productivity, and a clinician empowered with confidence. PMH turns musculoskeletal data into restored motion, restored trust, and restored livelihoods.